Axcelis Technologies, Inc. — Form 10-Q Summary
Business and period: Axcelis makes ion implantation, dry strip and other semiconductor-processing equipment, and provides related aftermarket services. This unaudited report covers the quarter and nine months ended September 30, 2012; amounts below are in millions unless stated otherwise.
Financial results
| Metric | Q3 2012 | Q3 2011 | 9M 2012 | 9M 2011 |
|---|---|---|---|---|
| Revenue | $44.6 | $72.5 | $158.8 | $259.0 |
| Gross profit / margin | $14.4 / 32.2% | $26.9 / 37.1% | $57.7 / 36.4% | $92.1 / 35.6% |
| Operating income (loss) | ($7.9) | ($0.2) | ($16.8) | $8.4 |
| Net income (loss) | ($8.7) | $1.2 | ($19.2) | $7.2 |
| Diluted EPS | ($0.08) | $0.01 | ($0.18) | $0.07 |
- Quarterly revenue fell about 38% year over year; nine-month revenue fell about 39%. Product revenue drove the decline, with system sales of $12.8 million in Q3 versus $35.1 million a year earlier.
- Q3 gross margin decreased 4.9 percentage points, principally due to lower system volume and under-absorption of fixed costs, including a $1.1 million charge related to lower-than-normal production capacity. A higher mix of parts and upgrades partly offset the impact. Nine-month gross margin increased 0.8 percentage points.
- Operating expenses declined year over year, but were insufficient to offset the revenue and gross-profit decline. Nine-month results also included $3.6 million of restructuring charges.
- Cash used in operating activities was $11.4 million for the first nine months, compared with $0.9 million provided in 2011. Capital expenditures were $0.5 million; cash and cash equivalents decreased to $35.2 million from $46.9 million at year-end 2011.
- At September 30, 2012, current assets were $188.5 million and current liabilities were $31.7 million. Total liabilities were $37.2 million; the filing reports no borrowings under its revolving facility during the quarter or nine-month period.
Changes, outlook and risks
- Management attributed weaker results to continued semiconductor-industry weakness and reduced customer capital spending. It anticipated similar market conditions in Q4 2012 and into 2013; no quantified revenue or earnings guidance was provided.
- Management said existing cash and cash equivalents were expected to meet anticipated short- and long-term cash requirements, and that spending could be aligned with demand. This outlook depends on market, revenue, expense and cash-flow assumptions.
- The revolving facility provides for up to $30 million of borrowing, primarily based on receivables. Available capacity was $18.5 million at quarter-end; the company was covenant-compliant after a September amendment revising the minimum trailing six-month Adjusted Net Income covenant. The facility terminates April 10, 2015.
- Restructuring followed a reduction in force intended to control costs, focus operations and conserve cash. The remaining $0.5 million liability was expected to be paid in Q4 2012.
- Revenue and cash flow are exposed to cyclical semiconductor capital spending, while much of the expense base is relatively fixed. Customer concentration was notable: three customers represented 40.1% of Q3 revenue; two customers represented 32.7% of nine-month revenue. Inventory was $123.3 million, including $20.2 million of reserves.
- The company reported no litigation it believed could materially adversely affect operations, no material changes to previously disclosed risk factors or market-risk information, and effective disclosure controls. A foreign tax dispute was settled for $0.9 million, equal to a previously recorded charge, with no reported effect on results or cash flows.
Investor verification points
- Assess whether semiconductor equipment demand and system sales recover, and how prolonged weakness could affect revenue, margins and cash usage.
- Review liquidity and the assumptions behind management’s cash-sufficiency outlook, including the $18.5 million available facility capacity and applicable covenants.
- Track inventory levels, reserves and production utilization, as well as customer concentration and receivables exposure.
- Confirm the completion and cash cost of restructuring and monitor whether expense reductions support a return to profitability.